GSK3B and early-onset autosomal dominant Alzheimer disease: A further exploration of PGRN-GSK3β signaling in neurodegenerative models, such as those for Alzheimer’s Disease, will be greatly valuable in fully understanding the mechanism behind PGRN’s protective role.